| 发明名称 | Use of the endoglycosidase endos for treating immunoglobulin G mediated diseases | ||
| 摘要 | The invention provides use of an EndoS polypeptide, or a polynucleotide encoding an EndoS polypeptide, in the manufacture of a medicament for the treatment or prevention of a disease or condition mediated by IgG antibodies. | ||
| 申请公布号 | US8889128(B2) | 申请公布日期 | 2014.11.18 |
| 申请号 | US200712518855 | 申请日期 | 2007.12.12 |
| 申请人 | Hansa Medical AB | 发明人 | Björck Lars;Collin Mattias;Olsén Arne;Holmdahl Rikard;Nandakumar Kutty Selva;Shannon Oonagh |
| 分类号 | A61K38/48;A61K39/02 | 主分类号 | A61K38/48 |
| 代理机构 | Kilpatrick Townsend & Stockton LLP | 代理人 | Kilpatrick Townsend & Stockton LLP |
| 主权项 | 1. A method of treating or preventing a disease or condition mediated by IgG antibodies in a subject in need thereof, wherein the method of treating the disease or condition comprises administering to the subject a therapeutically effective amount of the polypeptide consisting of SEQ ID NO: 1 and wherein the method of preventing the disease or condition comprises administering to the subject a prophylactically effective amount of the polypeptide consisting of SEQ ID NO: 1. | ||
| 地址 | Lund SE | ||